| Tips : |
Žurnāls |
| Interneta saite : |
https://doi.org/10.1007/s40268-023-00433-7 |
|
| Pētniecības grupas : |
Incheon - Quality Evaluation Team, Samsung Bioepis Co |
| Autori : |
Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park S-J. |
| Nosaukums : |
In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period. |
| Numurs : |
Drugs R D ;23,4:363 - 375 2023 |
|
| Pierādījumu līmeni : |
|
| Fizikālā stabilitāte : |
|
| ķīmiskā stabilitāte : |
|
| Citas metodes : |
|
| Komentāri : |
| Proteīni: bioloģiskā aktivitāte ar enzīmu metodi |
|
Saraksti
 Eculizumab
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
5 mg/ml |
2-8°C |
 |
| 90 |
 |
|
 |
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
 |
|
|
|
|
 |
5 mg/ml |
2-8°C |
|
| 90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
|
|
|
|
 |
|
5 mg/ml |
2-8°C |
|
| 90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
| 90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
|
|
|
|
|
